These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 31942840)

  • 1. Coenzyme Q10 administration has no effect on sICAM-1 and metabolic parameters of pediatrics with type 1 diabetes mellitus.
    Serag H; El Wakeel L; Adly A
    Int J Vitam Nutr Res; 2021 Jun; 91(3-4):315-324. PubMed ID: 31942840
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
    Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
    Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity.
    Brauner H; Lüthje P; Grünler J; Ekberg NR; Dallner G; Brismar K; Brauner A
    Clin Exp Immunol; 2014 Aug; 177(2):478-82. PubMed ID: 24593795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus.
    Eriksson JG; Forsén TJ; Mortensen SA; Rohde M
    Biofactors; 1999; 9(2-4):315-8. PubMed ID: 10416046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis.
    Suksomboon N; Poolsup N; Juanak N
    J Clin Pharm Ther; 2015 Aug; 40(4):413-8. PubMed ID: 25913756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10.
    Zhang YP; Song CY; Yuan Y; Eber A; Rodriguez Y; Levitt RC; Takacs P; Yang Z; Goldberg R; Candiotti KA
    Neurobiol Dis; 2013 Oct; 58():169-78. PubMed ID: 23684663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction and inflammatory biomarkers as a response factor of concurrent coenzyme Q10 add-on metformin in patients with type 2 diabetes mellitus.
    Al-Kuraishy HM; Al-Gareeb AI; Shams HA; Al-Mamorri F
    J Lab Physicians; 2019; 11(4):317-322. PubMed ID: 31929697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of coenzyme Q
    Huang H; Chi H; Liao D; Zou Y
    Diabetes Metab Syndr Obes; 2018; 11():875-886. PubMed ID: 30568475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: an open label pilot study.
    Mezawa M; Takemoto M; Onishi S; Ishibashi R; Ishikawa T; Yamaga M; Fujimoto M; Okabe E; He P; Kobayashi K; Yokote K
    Biofactors; 2012; 38(6):416-21. PubMed ID: 22887051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patients.
    Kolahdouz Mohammadi R; Hosseinzadeh-Attar MJ; Eshraghian MR; Nakhjavani M; Khorami E; Esteghamati A
    Minerva Gastroenterol Dietol; 2013 Jun; 59(2):231-6. PubMed ID: 23831913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.
    Lim SC; Caballero AE; Smakowski P; LoGerfo FW; Horton ES; Veves A
    Diabetes Care; 1999 Nov; 22(11):1865-70. PubMed ID: 10546021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutaredoxin mediated redox effects of coenzyme Q10 treatment in type 1 and type 2 diabetes patients.
    Montano SJ; Grünler J; Nair D; Tekle M; Fernandes AP; Hua X; Holmgren A; Brismar K; Ungerstedt JS
    BBA Clin; 2015 Dec; 4():14-20. PubMed ID: 26966682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antioxidant status of coenzyme Q10 and vitamin E in children with type 1 diabetes.
    Alkholy UM; Abdalmonem N; Zaki A; Elkoumi MA; Hashim MIA; Basset MAA; Salah HE
    J Pediatr (Rio J); 2019; 95(2):224-230. PubMed ID: 29425798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with Type 1 diabetes mellitus.
    Henriksen JE; Andersen CB; Hother-Nielsen O; Vaag A; Mortensen SA; Beck-Nielsen H
    Diabet Med; 1999 Apr; 16(4):312-8. PubMed ID: 10220205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of coenzyme Q10 and its ratio to cholesterol in the progress of chronic kidney diseases linked to non- -communicable diseases.
    Gvozdjakova A; Kucharska J; Sumbalova Z; Rausova Z; Chladekova A; Komlosi M; Szamosova M; Mojto V
    Bratisl Lek Listy; 2020; 121(10):693-699. PubMed ID: 32955899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of CoQ10 Supplementation on Lipid Profiles and Glycemic Control in Patients with Type 2 Diabetes: a randomized, double blind, placebo-controlled trial.
    Zahedi H; Eghtesadi S; Seifirad S; Rezaee N; Shidfar F; Heydari I; Golestan B; Jazayeri S
    J Diabetes Metab Disord; 2014; 13():81. PubMed ID: 26413493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled, pilot trial.
    Donnino MW; Mortensen SJ; Andersen LW; Chase M; Berg KM; Balkema J; Radhakrishnan J; Gazmuri RJ; Liu X; Cocchi MN
    Crit Care; 2015 Jul; 19(1):275. PubMed ID: 26130237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes.
    Zhang YP; Eber A; Yuan Y; Yang Z; Rodriguez Y; Levitt RC; Takacs P; Candiotti KA
    Anesthesiology; 2013 Apr; 118(4):945-54. PubMed ID: 23334664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy.
    Güler S; Cakir B; Demirbas B; Yönem A; Odabasi E; Onde U; Aykut O; Gürsoy G
    Horm Res; 2002; 58(2):67-70. PubMed ID: 12207164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes.
    Sourris KC; Harcourt BE; Tang PH; Morley AL; Huynh K; Penfold SA; Coughlan MT; Cooper ME; Nguyen TV; Ritchie RH; Forbes JM
    Free Radic Biol Med; 2012 Feb; 52(3):716-723. PubMed ID: 22172526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.